Manufacturing Chemist
  • Home
  • Categories
    • Ingredients
    • Analysis
    • Manufacturing
    • Finance
    • Company News
    • Regulatory
    • Drug Delivery
    • Research & Development
    • Sustainability
  • Pharma 5.0
  • Events
  • Directory
  • Editorial team
  • Search
    • Close search
  • Subscribe
  • Login
    • Password
      Password
      Forgot password? Close login form
  • Home
  • Company News

Company News

Amgen makes changes to board Amgen makes changes to board They will come into effect on 1 January 2013 Victrex team goes the distance for charity Victrex team goes the distance for charity Victrex team goes the distance for charity Peak District hike raises funds for The Christie in Manchester Dr Rabinder Buttar wins Scottish Asian Business Award Dr Rabinder Buttar wins Scottish Asian Business Award Dr Rabinder Buttar wins Scottish Asian Business Award ClinTec sees 15th year of continued growth Michael Koenig appointed to Bayer board of management Michael Koenig appointed to Bayer board of management Michael Koenig appointed to Bayer board of management Dr Richard Pott to retire, effective 1 June 2013 Sygnature Discovery appoints VP of Business Development – North America Sygnature Discovery appoints VP of Business Development – North America Plans to expand customer base in the US and Canada over next two years Charlie Morris joins Almac’s clinical technologies team Charlie Morris joins Almac’s clinical technologies team Charlie Morris joins Almac’s clinical technologies team Will oversee development of IXRS technology Penn Pharma boosts senior management team Penn Pharma boosts senior management team Adds Kat Jones as director of marketing and commercial operations Basilea appoints Ronald Scott as CEO Basilea appoints Ronald Scott as CEO Also expands management team with addition of Heidi McDaid Paul O’Nion joins RSSL Paul O’Nion joins RSSL Paul O’Nion joins RSSL To head the expansion of gas chromatography and mass spectrometry services Mymetics announces change of directors and management Mymetics announces change of directors and management Mymetics announces change of directors and management Will explore a number of strategic opportunities for its HIV, RSV and other vaccine candidates Novo Nordisk to create all-diabetes professional cycling team Novo Nordisk to create all-diabetes professional cycling team Team Novo Nordisk will promote the billion dollar drug that is never prescribed – exercise CEO Alex Gorsky elected chairman of Johnson & Johnson CEO Alex Gorsky elected chairman of Johnson & Johnson Bill Weldon to step down after 41-year career at the company Cambridge Major Laboratories hires VP of Science and Technology Cambridge Major Laboratories hires VP of Science and Technology Cambridge Major Laboratories hires VP of Science and Technology Dr Prasad Raje joins the company with 15 years of industry experience Onyx bolsters US team Onyx bolsters US team Onyx bolsters US team With the appointment of a business development director based in Chicago Shire appoints president of Regenerative Medicine business Shire appoints president of Regenerative Medicine business Jeff Jonas gains a promotion Manchester Organics creates position of global head of technical sales Manchester Organics creates position of global head of technical sales Manchester Organics creates position of global head of technical sales Jordi Robinson joins the company from Endeavour Speciality Chemicals
  • Previous
  • 1
  • …
  • 150
  • 151
  • 152
  • 153 (current)
  • 154
  • 155
  • 156
  • …
  • 216
  • Next

Trending Articles

  1. New Managing Director for Shimadzu Europa Dr. Florian Geistmann (pictured) takes over as Managing Director of Shimadzu Europa, succeeding Jürgen Semmler, who has retired after five years at the helm of the European organisation and more than 39 years in the company in total
  2. BioDuro appoints Greg Makara to lead discovery chemistry BioDuro has appointed Greg Makara, PhD, as Senior Vice President, Lead Discovery Chemistry, as the contract research, development and manufacturing organisation (CRDMO) looks to strengthen its early-stage drug discovery capabilities.
  3. EyeC expands OEM growth with new business development manager Rigel Gallegos will lead the development of EyeC’s OEM and system integrator business
  4. Three new commercial appointments for Symbiosis Symbiosis Pharmaceutical Services has expanded its commercial team with three new appointments as the specialist aseptic fill-finish CDMO targets further growth across Asia-Pacific, the Middle East and Southern Europe
  5. Lonza nominates Pearl Huang to board Lonza has nominated Pearl Huang as an independent member of its Board of Directors, bringing extensive pharmaceutical and biotechnology experience and expertise in drug discovery and innovation

Become a Subscriber

Subscribe now Already a subscriber? Sign in here. Find out more

Get our newsletter

Follow us

  • LinkedIn
  • About Manufacturing Chemist
  • About HPCi Media
  • Newsletter sign up
  • Contact Us
  • Advertise
© HPCi Media Limited | Registered in England No. 06716035 | VAT GB 939828072 | a Claverley Group company Registered office address:
One Anchorage Avenue,
Shrewsbury Business Park,
Shrewsbury,
SY2 6FG, UK. Terms and Conditions | Privacy